Eye on Innovation: Advancing AI Maturity
Planview’s Chief Data Scientist, Dr. Rich Sonnenblick, explores why most AI pilots never scale, and how connected intelligence moves organizations from experiments to enterprise impact.
Aggregated enterprise architecture wisdom
Planview’s Chief Data Scientist, Dr. Rich Sonnenblick, explores why most AI pilots never scale, and how connected intelligence moves organizations from experiments to enterprise impact.
Note from Editor: This post is adapted from Dr. Rich Sonnenblick’s presentation at the 30th European Biopharma Project, Program, & Portfolio Management Conference in Basel. In his presentation, Dr. Sonnenblick dispelled the hype surrounding AI and agents, while sharing concrete examples of how drug development teams are saving hundreds of hours, de-risking their clinical pipelines,…
When companies value stability over innovation, some risks increase: they risk slowly losing market share and fading into the background of their industry. So what do we do? The solution lies in the understanding that effective R&D governance cannot, and should not, distill projects into a single number. Here are five ways to assess and communicate risk in your portfolio.
A new paradigm is emerging in software development: the era of the LLM-native developer. This transformation isn’t about replacing developers with AI but redefining their roles. Planview’s Chief Data Scientist, Dr. Rich Sonnenblick, explains how.